Please assess the completion status of the following clinical trial:

Trial Title: BIO|CONCEPT.ECG-Library

Study Design Characteristics:
- Allocation: NON_RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: OTHER
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Patient is able to understand the nature of the study and willing to provide written informed consent.~* Patient is willing and able to attend Holter ECG procedure following a visit~* History of at least one of the following conditions (established via ECG prior to enrollment):~(A) Patient with pacemaker/ICD and~1. Ventricular stimulation \> 30 % or~   (B) Patient either without pacemaker/ICD or with pacemaker/ICD, but without significant atrial and ventricular stimulation and at least one of the following:~2. Frequent Ventricular Extrasystoles (VES) (incl. Bigeminus) or~3. Atrioventricular Reentrant Tachycardia (AVRT)/Wolff-Parkinson-White (WPW) syndrome or~4. Atrioventricular Nodal Reentrant Tachycardia (AVNRT) or~5. Sinus Tachycardia at rest or~6. Atrial Flutter or~7. Any form of Ventricular Tachycardia (VT) or~8. Silent/Paroxysmal/persistent/permanent AF or~9. Brugada syndrome or~10. Long QT syndrome or~11. Right Bundle Branch Block (RBBB) or~12. Left Bundle Branch Block (LBBB) or~13. Myocardial Ischemia/Acute Myocardial Infarction or~14. Other abnormal QRS(T) complex, ST segment or T-wave morphology, i.e. any other QRS anomaly / ST segment elevation / ST segment Depression / T wave changes~Exclusion Criteria:~* Any condition which precludes the patient's ability to comply with the study requirements.~* Known allergy to patch electrodes.~* Pregnant or breast feeding.~* Less than 18 years old.~* Participation in another interventional clinical investigation

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- 3-channel Holter ECG recording for EPS patient (Type: OTHER): Patients participating in an EPS will undergo a 3-channel Holter ECG recording in parallel to the standard 12-channel Holter ECG recording during the EPS followed by an optional 24 h observation period
- 12-channel Holter ECG recording for non-EPS patients (Type: OTHER): Patients scheduled for a follow-up for their heart disease will undergo a 12-channel Holter ECG recording while participating in a Body Motion test followed by a 24 h observation period

Based on this trial design, predict the completion outcome and termination type (if applicable).